Association between MucoidPseudomonasInfection and Bronchiectasis in Children with Cystic Fibrosis

Philip M. Farrell, Jannette Collins, Lynn S. Broderick, Michael J. Rock, Zhanhai Li, Michael R. Kosorok, Anita Laxova, William M. Gershan, Alan S. BrodyRadiology 2009 · DOI

TL;DR

This study reveals a strong association between the presence of mucoid Pseudomonas aeruginosa (PA) and the severity of bronchiectasis in children with cystic fibrosis (CF). The findings suggest that targeting and preventing infection with this specific mucoid strain of PA is crucial for mitigating irreversible lung damage in CF patients.

What Problem Does This Paper Address?

Cystic fibrosis (CF) is a genetic disorder that leads to chronic lung disease, primarily driven by recurrent respiratory infections. Bronchiectasis, a permanent structural abnormality of the lungs characterized by dilated airways, is an early and significant feature of CF lung disease. While various factors are suspected to contribute to bronchiectasis, a clear understanding of which specific pathogens or clinical factors are most strongly linked to its development and severity has been lacking. This gap hinders the development of targeted preventive strategies. The authors aimed to identify and quantify these determinants, particularly focusing on the role of Pseudomonas aeruginosa (PA), a common and problematic pathogen in CF.

Methods

The researchers conducted a longitudinal epidemiological evaluation of children with CF enrolled in the Wisconsin trial of newborn screening. They utilized thin-section chest computed tomography (CT) scans to objectively assess the severity of bronchiectasis. This CT data was analyzed using a standardized scoring system by multiple blinded raters. Microbiological data, specifically the differentiation of PA into mucoid and nonmucoid strains, was obtained from cultures of respiratory secretions. They then employed a general linear model to analyze the correlation between various potential risk factors (including clinical and microbiological variables) and the CT-derived bronchiectasis scores.

Datasets

The study used data from 82 children with cystic fibrosis who participated in the Wisconsin trial of newborn screening. This cohort was followed longitudinally, with CT scans performed on patients aged 6.6 to 17.6 years. Microbiological data from respiratory secretions were also collected. No new datasets or benchmarks were introduced; the study relied on existing patient data and established CT scoring methods.

Key Insights and Ideas

  • Mucoid PA as a Primary Driver: The most striking finding is that infection with mucoid Pseudomonas aeruginosa was the only one of 12 potential risk factors significantly correlated with the severity of bronchiectasis. This suggests mucoid PA is not merely a marker of disease but a direct contributor to its progression.
  • CT vs. PFTs for Early Detection: The study highlights that CT scanning can identify bronchiectasis even in children with normal pulmonary function tests (PFTs), underscoring its superior sensitivity for detecting early structural lung damage in CF.
  • Nonmucoid PA Less Critical for Bronchiectasis Severity: While nonmucoid PA is a precursor to mucoid PA and is known to colonize bronchiectatic airways, it did not show a significant correlation with the severity of bronchiectasis in this study, unlike its mucoid counterpart.
  • Age as a Contributing Factor: CT bronchiectasis scores increased significantly with age, indicating a progressive nature of the disease over time.

Key Results

  • High Prevalence of Bronchiectasis: A substantial 83% (68 of 82) of the participating children with CF showed bronchiectasis of varying severity.
  • Significant Correlation with Mucoid PA: The severity of bronchiectasis was significantly related to infection with mucoid PA (P = .041).
  • No Significant Correlation with Other Factors: None of the other 11 potential risk factors, including S. aureus infection, nonmucoid PA, aerosol antibiotic use, chronic antibiotic use, regular antibiotic use, sex, genotype, pancreatic status, meconium ileus, days with infection, or days with hospitalization, showed a significant correlation with bronchiectasis severity.
  • Age and Bronchiectasis: CT bronchiectasis scores increased significantly with age (P = .012).
  • CT vs. PFT Correlation: While PFTs showed significant negative correlations with CT bronchiectasis scores (indicating worse PFTs with more severe bronchiectasis), the study emphasizes that CT provides more localized and detailed information about structural damage.

Limitations and Future Work

The authors acknowledge that their study design is cross-sectional, which means it can demonstrate associations but not definitively prove causation. They also note that the number of patients investigated and the potential for confounding among independent variables are limitations. Future work could involve prospective studies to further elucidate the causal relationship between mucoid PA and bronchiectasis. The findings strongly support the need for aggressive strategies to prevent PA infection, particularly the transition to mucoid strains, in children with CF, emphasizing the importance of newborn screening and early, rigorous infection control measures.

Summary updated

Abstract

The severity of bronchiectasis in children with cystic fibrosis is significantly related to respiratory infection with mucoid PA; attempts to prevent bronchiectasis should include reducing exposure to and early eradication of PA.
BibTeX
@inproceedings{farrell2009association,
  author = {Philip M. Farrell and Jannette Collins and Lynn S. Broderick and Michael J. Rock and Zhanhai Li and Michael R. Kosorok and Anita Laxova and William M. Gershan and Alan S. Brody},
  title = {{Association between Mucoid<i>Pseudomonas</i>Infection and Bronchiectasis in Children with Cystic Fibrosis}},
  booktitle = {Radiology},
  year = {2009},
  doi = {10.1148/radiol.2522081882},
}
Figure